![]() |
Quick Reference Peptide Toxins |
|
|
CODE |
COMPOUND |
QTY |
USD |
| PAG-4256-s | w -Agatoxin-IVA | 0.1 mg vial | 335 |
| PAG-4294-s | w -Agatoxin TK CAS 145017-83-0 | 0.1 mg vial | 390 |
| PAG-4247-s | Agelenin | 0.1 mg vial | 335 |
| PAP-4257-v | Apamin CAS 24345-16-2 | 0.5 mg vial | 195 |
| PCC-4310-s | Calcicludine CAS 178037-96-2 | 0.1 mg vial | 309 |
| PCL-4255-s | Calciseptine CAS 178805-91-9 | 0.1 mg vial | 335 |
| PCB-4227-s | Charybdotoxin (ChTX) CAS 95751-30-7 | 0.1 mg vial | 235 |
| PCN-4282-v | Chlorotoxin | 0.5 mg vial | 563 |
| PCN-4126-v | a-Conotoxin GI CAS 76862-65-2 | 0.5 mg vial | 279 |
| PCN-4140-v | a-Conotoxin MI CAS 83481-45-2 | 0.5 mg vial | 285 |
| PCN-4311-v | a-Conotoxin ImI CAS 156467-85-5 | 0.5 mg vial | 285 |
| PCN-4228-v | a-Conotoxin SI CAS 115797-06-03 | 0.5 mg vial | 285 |
| PCN-4263-v | µ-Conotoxin GS | 0.5 mg vial | 419 |
| PCN-4217-v | µ-Conotoxin GIIIB CAS 140678-12-2 | 0.5 mg vial | 409 |
| PCN-4161-v | w -Conotoxin GVIA CAS 106375-28-4 | 0.5 mg vial | 397 |
| PCN-4283-s | w -Conotoxin MVIIC CAS 147794-23-8 | 0.1 mg vial | 167 |
| PCN-4283-v | w -Conotoxin MVIIC CAS 147794-23-8 | 0.5 mg vial | 369 |
| PCN-4289-v | w -Conotoxin MVIIA CAS 107452-89-1 | 0.5 mg vial | 329 |
| PCN-4284-v | w -Conotoxin SVIB CAS 150433-82-2 | 0.5 mg vial | 329 |
| PDN-4330-s | Dendrotoxin I CAS 129203-60-7 | 0.1 mg vial | 315 |
| PGX-4433-s | Guangxitoxin-1E (GxTX-1E) | 0.1 mg vial |
229 |
| PIB-4235-s | Iberiotoxin (IbTX) CAS 129203-60-7 | 0.1 mg vial | 239 |
| PIM-4343-s | Imperatoxin A (IpTXa) CAS 172451-37-5 | 0.1 mg vial | 235 |
| PKL-4259-s | Kaliotoxin (1-37) CAS 145199-73-1 | 0.1 mg vial | 259 |
| PAR-4290-s | Margatoxin (MGTX) CAS 145808-47-5 | 0.1 mg vial | 235 |
| PMC-4258-v | Mast Cell
Degranulating Peptide CAS 32908-73-9 |
0.5 mg vial | 279 |
| PMS-4107-v | Mastoparan CAS 72093-21-1 | 0.5 mg vial | 65 |
| PMT-4341-s | Muscarinic Toxin 1 (MTX1, MT1) | 0.1 mg vial | 315 |
| PMT-4340-s | Muscarinic Toxin 7 (MTX7, MT7) | 0.1 mg vial | 315 |
| PNT-4195-s | Neurotoxin, NSTX-3 CAS 69344-74-7 | 0.1 mg vial | 99 |
| PPL-4300-s | PLTX-II | 0.1 mg vial | 395 |
| PSF-4206-s | Sarafotoxin S6b CAS 116303-65-2 | 0.1 mg vial | 159 |
| PSF-4246-s | Sarafotoxin S6c CAS 121695-87-2 | 0.1 mg vial | 159 |
| PSC-4260-s | Scyllatoxin/Leiurotoxin | 0.1 mg vial | 229 |
| PCB-4363-s | SNX-482 | 0.1 mg vial |
330 |
| PSK-4287-s | Stichodactyla Toxin | 0.1 mg vial |
239 |
| PTK-4364-s | Tertiapin | 0.1 mg vial | 159 |
| PTT-4313-s | Tityustoxin Ka | 0.1 mg vial | 315 |
*All -s and -v
products are sold as net peptide weight. Some products are available in bulk quantities,
please inquire.
Conotoxin peptides are not available
for export without a license from the US Department of Commerce.
To place an order for conotoxin peptides to be shipped within the United States please
contact
Peptides International to obtain important information regarding the CDC Select Agent
Transfer Program .
Thank you for your cooperation!
Specific Channel Type |
Channel Blocker |
Effective Concentration |
Notes |
P-type |
w -Agatoxin TK |
IC50 = 15 nM |
Also blocks a Q-type-like Ca2+ channel in rat hippocampal neurons with low sensitivity |
w -Agatoxin IVA |
Kd = 2 nM |
Selective blocker with high affinity | |
N-type |
w -Conotoxin GVIA, |
100 nM - 2 m M |
Reversibly blocks synapse neurotransmitter release. |
w -Conotoxin MVIIA |
100 nM - 1 m M |
Highly potent blocker, competes with w -Conotoxin GVIA | |
w -Conotoxin SVIB |
100 nM - 2 m M |
Pre-synaptic blocker. | |
L-type |
Calciseptine |
100 nM - 2 m M |
Very specific and highly potent. |
Calcicludine |
L-type: IC50 = 200 pM |
Also blocks N- and P-types to a lesser extent | |
P/Q-type |
w -Conotoxin MVIIC |
50 nM - 1 m M |
Selective and highly potent |
R-type |
SNX-482 |
IC50 = 15 - 30 nM |
Specific for Class E subtype |
PLTX-II |
Pre-synaptic blocker. |
TYPE |
CODE |
COMPOUND |
QTY |
USD |
| Ca2+ Channel Blockers | ||||
| L-type | PCL-4255-s | Calciseptine | 0.1 mg vial | 335 |
| L-type | PCC-4310-s | Calcicludine (CaC) | 0.1 mg vial | 309 |
| N-type | PCN-4161-v | w -Conotoxin GVIA | 0.5 mg vial | 397 |
| N-type | PCN-4289-v | w -Conotoxin MVIIA | 0.5 mg vial | 329 |
| N-type | PCN-4284-v | w -Conotoxin SVIB | 0.5 mg vial | 329 |
| P-type | PAG-4256-s | w -Agatoxin IVA | 0.1 mg vial | 335 |
| P-type | PAG-4294-s | w -Agatoxin TK | 0.1 mg vial | 390 |
| P/Q-type | PCN-4283-s | w -Conotoxin MVIIC | 0.1 mg vial | 167 |
| P/Q-type | PCN-4283-v | w -Conotoxin MVIIC | 0.5 mg vial | 369 |
| R-type | PCB-4363-s | SNX-482 | 0.1 mg vial | 330 |
| PPL-4300-s | PLTX-II | 0.1 mg vial | 395 | |
| K+ Channel Blocker | ||||
| Ca2+ Activated K+ Channel Blockers | ||||
| BK-type1 | PIB-4235-s | Iberiotoxin (IbTX) | 0.1 mg vial | 239 |
| BK-type1 | PKL-4259-s | Kaliotoxin (1-37) | 0.1 mg vial | 259 |
| IK-type2 | PCB-4227-s | Charybdotoxin* (ChTX) | 0.1 mg vial | 235 |
| SK-type3 | PAP-4257-v | Apamin | 0.5 mg vial | 195 |
| SK-type3 | PSC-4260-s | Scyllatoxin (Leiurotoxin I) | 0.1 mg vial | 229 |
| 1 High Conductance; 2 Intermediate Conductance; 3 Small Conductance *also has BK-type blocking activity | ||||
| Voltage Dependent K+ Channel Blockers | ||||
| PMC-4258-v | Mast Cell Degranulating (MCD) Peptide | 0.5 mg vial | 279 | |
| PSK-4287-s | Stichodactyla Toxin (ShK) | 0.1 mg vial | 239 | |
| PAR-4290-s | Margatoxin (MgTX) | 0.1 mg vial | 235 | |
| PTT-4313-s | Tityustoxin Ka (TsTX-K ) | 0.1 mg vial | 315 | |
| PDN-4330-s | Dendrotoxin I | 0.1 mg vial | 315 | |
| Na+ Channel Blockers | ||||
| PCN-4217-v | µ-Conotoxin GIIIB | 0.5 mg vial | 409 | |
| PCN-4263-v | µ-Conotoxin GS | 0.5 mg vial | 419 | |
| Cl- Channel Blocker | ||||
| PCN-4282-v | Chlorotoxin | 0.5 mg vial | 563 | |
To Order Contact
Peptides International Inc.
11621 Electron Drive
Louisville, Kentucky 40299
Call 800-777-4779 (USA and Canada) or
502-266-8787
Fax 502-267-1FAX (1329) or E-mail: peptides@pepnet.com
HOME | Back to Quick Reference | Back to Products | E-mail